We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · February 20, 2021

Emricasan to Prevent New Decompensation in NASH-Related Decompensated Cirrhosis

Journal of Hepatology


Additional Info

Journal of Hepatology
Emricasan to Prevent New Decompensation in Patients With NASH-Related Decompensated Cirrhosis
J. Hepatol. 2021 Feb 01;74(2)274-282, C Frenette, Z Kayali, E Mena, PS Mantry, KJ Lucas, G Neff, M Rodriguez, PJ Thuluvath, E Weinberg, BR Bhandari, J Robinson, N Wedick, JL Chan, DT Hagerty, KV Kowdley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading